Brewin Dolphin's Q3 2021: Quarterly Review

Strong growth in profits provided a boost to company shares during the third quarter of 2021, but anxiety over the future tempered those gains. In their recent report, Criticaleye Advisory Member, Brewin Dolphin, looks back at the events that have shaped markets over the past three months and highlight what to expect in 2022. 
 
Key takeaways include:
  • Some of the supply shortages can be blamed on companies that misjudged what lockdown would mean, in terms of goods demand.
  • ‘Upstream’ oil prices have been rising but, towards the end of the quarter, oil availability became an even greater problem ‘downstream’, as a shortage of HGV drivers made it difficult to get petrol to filling stations.
  • Going into 2022, it seems likely that monetary policy will tighten.




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Criticaleye Asia Podcast - Su...

Joe Dische, CFO, PropertyGuru Group, shares his perspective on what it means to succeed as a strategic CFO during times of transformation. With over two decades of experience across technology, media and telecom sectors...

Click here to download this insight
Inside The Take Private at Pr...

After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...

Inspiring Leaders Podcast: Le...

Rob Hornby, Co-CEO of AlixPartners and Rita Clifton CBE, Portfolio Chair and Non-Executive Director (including Deputy Chair of the John Lewis Partnership, Chair of Simplyhealth, Chair of the international sustainability...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 484




NATS Concentrix E.ON UK Drax Group plc Rolls-Royce Google Hitachi Solutions Palo Alto Networks British Land Worldpay Lightsource bp Eightfold AI London Stock Exchange Group Legal & General NatWest Group AlixPartners Workday Accenture Aldermore Group Salesforce FTSE Women Leaders Review IBM Consulting GlaxoSmithKline plc